NCT05442203View on ClinicalTrials.gov

Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 7, 2022

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Atrial FibrillationStructural Heart Disease
Interventions
DEVICE

Zio Patch Monitor

Patch monitor will be applied and worn for a 2-week period at baseline, month 6, and month 12 after assignment to the AF arm.

DEVICE

Echocardiogram

Ultrasound study of the heart will be completed upon patient consent after assignment to the SHD arm.

Trial Locations (3)

17822

Geisinger Medical Center, Danville

45242

TriHealth, Cincinnati

49503

Corewell Health, Grand Rapids

All Listed Sponsors
lead

Tempus AI

INDUSTRY